1. Home
  2. PHGE vs NCL Comparison

PHGE vs NCL Comparison

Compare PHGE & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • NCL
  • Stock Information
  • Founded
  • PHGE 2015
  • NCL 2013
  • Country
  • PHGE Israel
  • NCL United States
  • Employees
  • PHGE N/A
  • NCL N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • NCL
  • Sector
  • PHGE Health Care
  • NCL
  • Exchange
  • PHGE Nasdaq
  • NCL Nasdaq
  • Market Cap
  • PHGE 13.3M
  • NCL 12.2M
  • IPO Year
  • PHGE N/A
  • NCL 2023
  • Fundamental
  • Price
  • PHGE $0.60
  • NCL $0.20
  • Analyst Decision
  • PHGE Strong Buy
  • NCL
  • Analyst Count
  • PHGE 2
  • NCL 0
  • Target Price
  • PHGE $13.50
  • NCL N/A
  • AVG Volume (30 Days)
  • PHGE 126.6K
  • NCL 1.1M
  • Earning Date
  • PHGE 04-02-2025
  • NCL 04-15-2025
  • Dividend Yield
  • PHGE N/A
  • NCL N/A
  • EPS Growth
  • PHGE N/A
  • NCL N/A
  • EPS
  • PHGE N/A
  • NCL N/A
  • Revenue
  • PHGE N/A
  • NCL $15,576,857.00
  • Revenue This Year
  • PHGE N/A
  • NCL N/A
  • Revenue Next Year
  • PHGE N/A
  • NCL N/A
  • P/E Ratio
  • PHGE N/A
  • NCL N/A
  • Revenue Growth
  • PHGE N/A
  • NCL 47.13
  • 52 Week Low
  • PHGE $0.48
  • NCL $0.15
  • 52 Week High
  • PHGE $6.30
  • NCL $0.76
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 35.68
  • NCL 35.87
  • Support Level
  • PHGE $0.60
  • NCL $0.19
  • Resistance Level
  • PHGE $0.69
  • NCL $0.24
  • Average True Range (ATR)
  • PHGE 0.11
  • NCL 0.02
  • MACD
  • PHGE -0.04
  • NCL -0.00
  • Stochastic Oscillator
  • PHGE 3.10
  • NCL 18.82

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.

Share on Social Networks: